APAC

Global breathing circuits market to hit $2.16b by 2029

Global breathing circuits market to hit $2.16b by 2029

Its growth is attributed to an increase in surgical procedures and a rise in chronic diseases.

Short-acting insulin market to cross $9b by 2030

Key drivers include technological advancements and evolving healthcare policies.

APAC to lead growth in the global cardiac tissue engineering market

The region’s expansion is attributed to a rise in cardiovascular disease, 

Mass spectrometry market to rise at 12.26% CAGR through 2028

Thanks to an increased investment in pharmaceutical and biopharmaceuticals.

Global intraocular lens market to grow by $1.17b through 2028

Its expansion is attributed to a rise in ophthalmic diseases, particularly cataracts.

How can hospitals boost their cyber defences?

Losing access to patient data and equipment is not just about privacy; it can also be deadly.

Prosthetic robot arm market to rise at 14.8% CAGR through 2028

The market is witnessing a trend towards 3D printing technology.

COVID-19 accelerates digital health innovations

The digital health market is set to reach $15.4b by 2030.

Medical billing outsourcing market to reach $45.8b by 2033

Its growth is attributed to the increasing complexity of healthcare billing processes.

APAC to record fastest growth in global burn care market

One key driver is the expansion of healthcare centres in countries, such as China and India.

Global heparin market to be valued at $15b by 2030

One key driver is the innovation in drug delivery systems and formulations.

What’s driving the global gastric cancer diagnostics market?

One key trend is the integration of molecular diagnostics such as next-generation sequencing.

Orthokeratology lens market to grow at 6.39% CAGR through 2028

Thanks to an increased demand for non-surgical vision correction alternatives.

Sleep apnea diagnostic systems market to reach $1.3b by 2033

The sector is driven by AI integration and a focus on home monitoring.

APAC local pharmaceutical firms challenge multinational dominance

This development is attributed to increased R&D investments and supportive government policies.

Neurological devices market to be valued at $20.9b by 2033

The sector’s growth is attributed to a rising prevalence of neurological disorders.